Biotest share

Shareholder information

Shareholder Structure

The data shown was taken in each case from the latest announcement communicated by the shareholder.

On account of an amendment to the German Securities Trading Act which came into force end of 2015 as a result of the implementation of the Transparency Directive/ Amending Directive (Transparenzrichtlinie-Änderungsrichtlinie) Biotest has published on January 14, 2016 a notification of existing voting rights, pursuant to section 41, para. 4f of the German Securities Trading Act (WpHG) of the District of Biberach which submitted this notification controlling the Kreissparkasse Biberach ("KSK"). Even if this notification of existing voting rights shows a voting share in Biotest AG of zero, the KSK is economically speaking still anchor shareholder of Biotest AG and has retained its Biotest shareholding and not reduced it to zero. For further information*

Ordinary Shares:
Release according to § 21 Abs. 1 WpHG
50.03%   OGEL GmbH
15.17%   Kreissparkasse Biberach
The voting rights stated below should be assigned to the companies according to § 22 Abs.1 Satz 1 Nr. 6 WpHG:
7.43%   BWInvest Baden-Württembergische
Investmentgesellschaft mbH, Stuttgart
     
Preference Shares:
100.00%   Free float

* Presse release of Biotest AG dated January 14th, 2016: "Kreissparkasse Biberach continues to be major shareholder of Biotest"

Dreieich, 14. January 2016. "Biotest has today published a notification of existing voting rights, pursuant to section 41, para. 4f of the German Securities Trading Act (WpHG) of the District of Biberach which submitted this notification controlling the Kreissparkasse Biberach ("KSK"). Even if this notification of existing voting rights shows a voting share in Biotest AG of zero, the KSK is economically speaking still anchor shareholder of Biotest AG and has retained its Biotest shareholding and not reduced it to zero.

The background to this technical notification of existing voting shares is an amendment to the German Securities Trading Act which recently came into force as a result of the implementation of the Transparency Directive/ Amending Directive (Transparenzrichtlinie-Änderungsrichtlinie) on the European harmonization of participation transparency which we would like to explain as follows:

The KSK holds its shareholding in Biotest AG via so-called legally independent open special funds ("Special Alternative Investment Funds" or "Special AIFs"). As a result of the aforementioned amendment to the German Securities Trading Act, which became effective at the end of November 2015, investors in such a Special AIF (in this case the KSK) no longer fall under the voting rights notification obligation according to sections 21 et sqq. of the German Securities Trading Act which was the case, until today.

In this respect, the KSK, as investor in such a "Special AIF", and the District of Biberach controlling the KSK, which have both to date been subject to notification obligations according to sections 21 et sqq. of the German Securities Trading Act, are obliged to submit a notification of existing voting shares according to section 41, para. 4f of the German Securities Trading Act by 15 January 2016 and to state a voting share reduced to zero, although the KSK is economically speaking holder of the respective Biotest ordinary shares. The District of Biberach has met this obligation with today's published notification of existing voting shares."